The worldwide market for prescription dermatological products exceeded 21 billion dollars last year, rising to $21.2 billion in 2015, according to the report World Market for Prescription Dermatological Drugs, 9th Edition (Antiacne, Antiaging, Dermatitis, Hair Loss, Psoriasis, Skin Cancer, Melasma and Seborrhea Treatments). 

Demand for prescription dermatological drugs is growing at a rate of 7.9%, from 2013 to 2015.

The driving forces for this market include growth and aging of the worldwide population, new products and technologies, and focus on lifestyle treatments that improve the effects of aging and damage to the skin,” said Bruce Carlson, Publisher of Kalorama Information. 

Among those that showed dramatic gain in the last two years are psoriasis, and skin cancer treatments dermatology drug sectors. Sales of prescription acne and rosacea and other drugs reflected a slower growth rate during this period, due to the fact that many of the drugs are older and have lost patent protection, according to Kalorama.